Article ID Journal Published Year Pages File Type
3283797 Clinical Gastroenterology and Hepatology 2009 8 Pages PDF
Abstract
Patients with ulcerative colitis given prolonged-release oral mesalamine 2 g once daily had better remission rates, acceptability, and self-reported adherence to therapy compared with patients given oral mesalamine 1 g twice daily.
Related Topics
Health Sciences Medicine and Dentistry Gastroenterology
Authors
, , , , , , , , , , , , , , ,